Krystexxa Injection


Indications and Reactions:

Role Indications Reactions
Primary
Premedication 37.0%
Gout 25.1%
Product Used For Unknown Indication 23.9%
Gouty Tophus 3.5%
Pulmonary Hypertension 1.5%
Prophylaxis 1.4%
Pain 1.1%
Gouty Arthritis 1.0%
Atrial Fibrillation 0.8%
Diabetes Mellitus 0.7%
Hypertension 0.7%
Nutritional Supplementation 0.6%
Blood Cholesterol Increased 0.5%
Off Label Use 0.5%
Urate Nephropathy 0.5%
Renal Impairment 0.3%
Renal Transplant 0.3%
Thyroid Disorder 0.3%
Anticoagulant Therapy 0.2%
Anxiety 0.2%
Therapeutic Response Decreased 34.0%
Infusion Related Reaction 24.5%
Gout 15.1%
Anaphylactic Reaction 2.8%
Anaphylactic Shock 2.8%
Type Iv Hypersensitivity Reaction 2.8%
Drug Ineffective 1.9%
Hypersensitivity 1.9%
Oedema Peripheral 1.9%
Pyrexia 1.9%
Rash 1.9%
Anaphylactoid Reaction 0.9%
Asthenia 0.9%
Blood Creatinine Increased 0.9%
Blood Glucose Increased 0.9%
Blood Pressure Increased 0.9%
Burning Sensation 0.9%
Dyspepsia 0.9%
Fatigue 0.9%
Haemolysis 0.9%
Secondary
Premedication 35.7%
Gout 27.1%
Product Used For Unknown Indication 18.6%
Gouty Tophus 6.1%
Prophylaxis 2.3%
Urate Nephropathy 2.3%
Pulmonary Hypertension 1.8%
Gouty Arthritis 1.1%
Pain 1.1%
Renal Impairment 0.8%
Hypertension 0.7%
Diabetes Mellitus 0.6%
Blood Cholesterol Abnormal 0.3%
Nutritional Supplementation 0.3%
Blood Cholesterol Increased 0.3%
Proteinuria 0.3%
Cardiovascular Event Prophylaxis 0.2%
Blood Pressure Abnormal 0.2%
Heart Transplant 0.2%
Rheumatoid Arthritis 0.2%
Therapeutic Response Decreased 47.8%
Infusion Related Reaction 17.9%
Fatigue 6.0%
Dyspepsia 4.5%
Gout 4.5%
Anaphylactic Shock 3.7%
Somnolence 2.2%
Asthenia 1.5%
Nasal Discomfort 1.5%
Pain In Extremity 1.5%
Therapeutic Response Unexpected 1.5%
Urticaria 1.5%
Anaphylactic Reaction 0.7%
Anaphylactoid Reaction 0.7%
Blood Glucose Increased 0.7%
Blood Pressure Increased 0.7%
Burning Sensation 0.7%
Drug Ineffective 0.7%
Hypersensitivity 0.7%
Palpitations 0.7%

Drug Data